Have p53 gene mutations and protein expression a different biological significance in colorectal cancer?

Journal of Cellular Physiology

Volumn 191, Issue 2, 2002, Pages 237-246

  Bazan, Viviana ^a   Migliavacca, Manuela ^a   Tubiolo, Carla ^a   Macaluso, Marcella ^a   Zanna, Ines ^a   Corsale, Simona ^a   Amato, Antonella ^b   Calò, Valentina ^a   Dardanoni, Gabriella ^b   Morello, Vincenza ^a   Farina, Mario La ^c   Albanese, Ida ^c   Tomasino, Rosa Maria ^d   Gebbia, Nicola ^b   Russo, Antonio ^c  

^a UNIVERSITY OF PALERMO   (Italy)

^b Department of Cellular and Development Biology ^*  (Italy)

^c Epidemiological Observatory Center of Sicilian Region   (Italy)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; PROTEIN P53;

ARTICLE; CANCER GENETICS; COLORECTAL CANCER; CONTROLLED STUDY; FLOW CYTOMETRY; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS;

EID: 18344373522     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10088     Document Type: Article

References (42)

1. Expression of high p53 levels in colorectal cancer: A favourable prognostic factor
2. Ras and myc analysis in primary and metastatic colorectal carcinomas: Specific ras mutations are associated with Dukes'D stage and mucinous histotype
3. Overexpression of p53 and long-term survival in colon carcinoma
4. Trends in right- and left-sided colon cancer
5. p53 gene alteration and protein accumulation in colorectal cancer
6. TP53 and long-term prognisis in colorectal cancer: Mutations in the zinc-binding domain predict poor survival
7. Cytoplasmic accumulation of p53 protein: An independent prognostic indicator in colorectal adenocarcinomas
8. p53 and k-ras as prognostic factors for Dukes' stage B colorectal cancer
9. Mechanism of p53 degradation
10. Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations
11. p53 gene point mutations in relation to p53 nuclear protein accumulation in colorectal cancers
12. Regression models and life tables
13. Influence of tumor localization on the prognostic value of p53 protein in colorectal adenocarcinomas
14. Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas
15. Tumor suppressor genes
16. p53 point mutation and survival in colorectal cancer patients
17. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
18. p53 gene mutation inside and outside of exon 5-8: The patterns differ in breast and others cancers
19. P53 mutations in human cancers
20. P53 mutations are present in colorectal cancer with cytoplasmic p53 accumulation
21. Conserved region mutations of the p53 gene are concentrated in distal colorectal cancers
22. Staining patterns of p53 immunohistochemistry and their biological significance in colorectal cancer
23. Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and no familial adenomatous polyposis patients
24. Prognostic value of p53 genetic change in colorectal cancer
25. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain
26. Optimization of RNA and DNA purification procedures from human colorectal carcinomas
27. P53 and human cancers
28. MDM2-arbiter of p53's destruction
29. Prognostic significance of p53 abnormalities in colorectal carcinoma detected by PCR-SSCP and immunohistochemical analysis
30. When the message goes awry: Disease-producing mutations that influence mRNA content and performance
31. Vimentin expression, proliferating cell nuclear antigen and flow cytometric factors
32. Prognostic significance of proliferative activity, DNA-ploidy, p53 and ki-ras point mutations in colorectal liver metastases
33. Regulation and function of the p53 tumor suppressor protein
34. p53 in colorectal cancer: Clinicopathological correlation and prognostic significance
35. Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma
36. Prognostic significance of p53 nuclear and cytoplasmic overexpression in right and left colorectal adenocarcinomas
37. The role ofp53-target genes in human cancer
38. p53 expression in stage III-IV squamous-cell carcinoma of the larynx: An immunohistochemical study related to clinico-pathological flow-cytometric DNA analysis and prognosis
39. Cancer of the colon: The influence of no-touch isolation technique on survival rates
40. p53 gene status and expression of p53, mdm2, and p21 Waf 1/Cip1 proteins in colorectal cancer
41. Causes, relevant mechanisms, and prevention of large bowel cancer
42. Nonisotopic SSCP detection in PCR products by ethidium bromide staining